T-cell research sheds light on why HIV can persist despite treatment

Research by an international team provides evidence that a particular T-cell type may help researchers better understand why HIV can persist despite treatment.

Share:

Total shares:

FULL STORY

Ryan Zurakowski (left), shown with doctoral student Fabian Cardozo, is co-author of a paper appearing in Nature Medicine highlighting the role of T-cells in HIV.

Credit: University of Delaware

Ryan Zurakowski (left), shown with doctoral student Fabian Cardozo, is co-author of a paper appearing in Nature Medicine highlighting the role of T-cells in HIV.

Credit: University of Delaware

Ryan Zurakowski, assistant professor of electrical and computer engineering at the University of Delaware, is co-author of a paper appearing in Nature Medicine on Jan. 12 highlighting the role of T-cells in HIV.

Zurakowski's co-authors include Mathias Lichterfeld, the paper's lead author, and researchers from Massachusetts General Hospital (MGH); Ragon Institute of MGH, the Massachusetts Institute of Technology and Harvard University; the First Affiliated Hospital of China Medical University; Brigham and Women's Hospital; and Howard Hughes Medical Institute.

Zurakowski explained that HIV treatments do not kill infected cells. Instead, they stop the infection of new cells, and rely on the virus itself to kill the infected cells. Unfortunately, some cells infected by the virus -- memory T-cells -- are not killed by the virus.

T-cells are a type of lymphocyte, or white blood cell, produced by the thymus gland, that actively participates in the body's immune response. "Memory" T-cells can live for years, or even decades, providing life-long immunity to previously encountered diseases. They can form "quiescent" infections, which last for years, and cause HIV to rebound whenever a patient stops treatment.

During a decade-long study, the researchers discovered that not all memory T-cells are alike. A subgroup of memory T-cells, called "Stem-Cell Memory T-cells" (Tscm), are different, particularly in their ability to produce daughter cells.

The researchers were able to show that the HIV-infected Tscm cells in patients on HIV therapy decayed more slowly than any other type of T-cell. As a result, after 10 years of therapy, the Tscm cells represented 24 percent of the total HIV infected cell population, despite being only 1 percent of the total T-cell population.

This finding is significant, Zurakowski said, because it demonstrates that Tscm cells are the slowest-decaying portion of the HIV reservoir.

"Over time this particular cell type plays an increasingly significant role in sustaining HIV infection in patients that have remained on therapy," he said.

Zurakowski credits the finding to the diligence of Lichterfeld and the researchers at the Ragon Institute in carefully following the same HIV patients for a decade.

"Because the researchers have followed the same patients over a decade, we have created a high fidelity data set that would not otherwise have been possible," he said.

Drugs currently being developed for cancer therapy that target stem-cell metabolic pathways may be able to target this cell type as well, due to the "stem-cell like" nature of the Tscm cells, he continued.

A better understanding of how the HIV virus leverages a cell's stem cell-like properties of cellular immune memory to stay alive could lead to improved clinical strategies for HIV treatment.

"If we can find a way to selectively eliminate the HIV-infected Tscm cells, it will be a major step in developing a true 'cure' for HIV infection," concluded Zurakowski.

University of Delaware. "T-cell research sheds light on why HIV can persist despite treatment." ScienceDaily. ScienceDaily, 14 January 2014. <www.sciencedaily.com/releases/2014/01/140114092140.htm>.

University of Delaware. (2014, January 14). T-cell research sheds light on why HIV can persist despite treatment. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2014/01/140114092140.htm

University of Delaware. "T-cell research sheds light on why HIV can persist despite treatment." ScienceDaily. www.sciencedaily.com/releases/2014/01/140114092140.htm (accessed August 2, 2015).

July 31, 2015  School is just around the corner, which means backpacks and packed lunches await your children. One expert offers tips for parents to promote healthy dental habits while away from ... read more

July 29, 2015  By blocking the expression of a certain gene in patients, researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

Dec. 18, 2014  Scientists are challenging dogma about the transmission of the human immunodeficiency virus type 1 (HIV-1). Most research has focused on infection by free viral particles, while this group of ... read more

June 3, 2014  By analyzing the blood of almost 100 treated and untreated HIV-infected volunteers, a team of scientists has identified previously unknown characteristics of B cells in the context of HIV infection. ... read more

Apr. 17, 2013  Researchers have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery could lead to novel approaches ... read more

Feb. 24, 2011  Although untreated HIV infection eventually results in immunodeficiency (AIDS), a small group of people infected with the virus, called elite suppressors (0.5 percent of all HIV-infected ... read more